Updated Jul 16, 2026 · Last SEC filing 2026-06-16
PULSE BIOSCIENCES, INC. (PLSE) has filed 9 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-16. 5 Form 8-K material event filings were reported by PLSE in the last 90 days. InsiderAlpha tracks every PLSE SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Surgical & Medical Instruments & Apparatus (SIC 3841) |
|---|---|
| SEC CIK | 0001625101 |
| Form 4 filings (90d) | 9 |
|---|---|
| Form 8-K filings (90d) | 5 |
| Latest Form 4 filing | 2026-06-16 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| LAVIOLETTE PAUL A | Chief Executive Officer | P — Open-market purchase | 15.0K | $19.69 | $295K | SEC | |
| DUGGAN ROBERT W | Director | P — Open-market purchase | 660.2K | $19.69 | $13.00M | SEC | |
| LAVIOLETTE PAUL A | Chief Executive Officer | P — Open-market purchase | 15.0K | $19.69 | $295K | SEC | |
| DUGGAN ROBERT W | Director | P — Open-market purchase | 660.2K | $19.69 | $13.00M | SEC | |
| Danahy Kevin Patrick | Chief Commercial Officer | M — Option exercise [10b5-1] | 5.0K | $1.53 | $8K | SEC | |
| Danahy Kevin Patrick | Chief Commercial Officer | S — Open-market sale [10b5-1] | 5.0K | $23.64 | $118K | SEC | |
| Danahy Kevin Patrick | Chief Commercial Officer | S — Open-market sale [10b5-1] | 20.0K | $23.63 | $473K | SEC | |
| Danahy Kevin Patrick | Chief Commercial Officer | M — Option exercise [10b5-1] | 20.0K | $1.53 | $31K | SEC | |
| Danahy Kevin Patrick | Chief Commercial Officer | S — Open-market sale [10b5-1] | 20.0K | $23.53 | $471K | SEC | |
| Danahy Kevin Patrick | Chief Commercial Officer | M — Option exercise [10b5-1] | 20.0K | $1.53 | $31K | SEC | |
| Danahy Kevin Patrick | Chief Commercial Officer | M — Option exercise [10b5-1] | 20.0K | $1.53 | $31K | SEC | |
| Danahy Kevin Patrick | Chief Commercial Officer | S — Open-market sale [10b5-1] | 20.0K | $23.37 | $467K | SEC | |
| Danahy Kevin Patrick | Chief Commercial Officer | M — Option exercise [10b5-1] | 20.0K | $1.53 | $31K | SEC | |
| Danahy Kevin Patrick | Chief Commercial Officer | S — Open-market sale [10b5-1] | 20.0K | $25.20 | $504K | SEC | |
| Danahy Kevin Patrick | Chief Commercial Officer | S — Open-market sale [10b5-1] | 20.0K | $23.52 | $470K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for PULSE BIOSCIENCES, INC. (PLSE). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| DUGGAN ROBERT W | 4 | $26.00M |
| van den Broek Richard | 2 | — |
| Zanganeh Mahkam | 2 | — |
| LAVIOLETTE PAUL A | 2 | $591K |
| Sainz Maria | 2 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in PLSE insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live PLSE dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.